A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

NCT07334301 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Neuroblastoma

Interventions

DRUG: Bevacizumab
DRUG: Dinutuximab beta
DRUG: Irinotecan (drug)
DRUG: Topotecan
DRUG: Temozolomide (TMZ)
DRUG: Temozolomide (TMZ)

Sponsor

University of Birmingham